Emerging studies suggest Retatrutide , a dual agonist targeting both GLP-1 and GIP , could provide a notable step forward for weight loss . Preliminary human trials have indicated substantial losses https://dawudnjso108034.wikikali.com/2188797/the_retatrutide_peptide_compound_a_innovation_in_weight_management